Header Logo

Connection

Robert Balk to Immunoglobulins

Back to Details
This is a "connection" page, showing publications Robert Balk has written about Immunoglobulins.
Robert Balk
Connection Strength
0.032
Immunoglobulins
  1. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Crit Care Med. 1995 Jun; 23(6):994-1006.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.